Science Explorer Back to mapMap
Discussion
Researcher · Canadian Red Cross Society · Canada

Shilpa Mankikar

Shilpa Mankikar publishes mostly in Immunology, Epidemiology and Oncology, on topics such as Inflammation biomarkers and pathways, Immune cells in cancer and Viral gastroenteritis research and epidemiology.

OpenAlex
World rank
#3,186,836
of 7,710,434 ranked researchers
Rank in Canada
#101,907
of 183,316
Works
15
Citations
608
Citations per work
40.5
h-index
6
i10-index 3Top 93% in Immunology
Shilpa Mankikar

What does Shilpa Mankikar research?

Shilpa Mankikar's work is mostly in Immunology and Microbiology (39%), Medicine (32%), Agricultural and Biological Sciences (5%).

Life Sciences: 7 works · 43.9% of their workImmunology and Microbiology: 6 works · 39.0% of their workImmunology: 6 works · 39.0% of their workAgricultural and Biological Sciences: 1 works · 4.9% of their workAnimal Science and Zoology: 1 works · 4.9% of their workHealth Sciences: 5 works · 31.7% of their workMedicine: 5 works · 31.7% of their workEpidemiology: 1 works · 9.8% of their workHepatology: 1 works · 7.3% of their workInfectious Diseases: 1 works · 7.3% of their workOncology: 1 works · 7.3% of their workEverything else: 4 works · 24.4% of their workTHEIR WORKShilpa Mankikar15works
Life Sciences44%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology639.0%
    2. Agricultural and Biological Sciences14.9%
    1. Medicine531.7%
  3. Everything else424.4%
  1. 1Immunology39% of their works
  2. 2Epidemiology10% of their works
  3. 3Oncology7% of their works
  4. 4Hepatology7% of their works
  5. 5Infectious Diseases7% of their works
  6. 6Animal Science and Zoology5% of their works

Research topics

Which keywords describe Shilpa Mankikar's research?

The keywords of their largest research topics: Immune Response, Inflammation, Epidemiology, Endocan, TREM-1, Activation, Macrophage and Pathogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Immune Response124 topics
  2. Inflammation112 topics
  3. Epidemiology73 topics
  4. Endocan61 topic
  5. TREM-161 topic
  6. Activation51 topic
  7. Macrophage51 topic
  8. Pathogenesis52 topics
  9. Vaccine52 topics
  10. Antiviral Therapy42 topics
  11. Liver Disease42 topics
  12. Norovirus31 topic
  13. Rotavirus31 topic
  14. Chronic Hepatitis B21 topic
  15. Coronavirus21 topic
  16. Hepatitis B Virus21 topic
  17. Hepatitis C Virus21 topic
  18. NK Cell Recognition21 topic
  19. Natural Killer Cells21 topic
  20. Porcine Reproductive and Respiratory Syndrome Virus21 topic
  21. Treatment21 topic
  22. Melanin11 topic
  23. Pigmentation11 topic

Where does Shilpa Mankikar work?

Shilpa Mankikar's main affiliation in the publication record is Canadian Red Cross Society, Canada.

How many publications and citations does Shilpa Mankikar have?

OpenAlex counts 15 works and 608 citations for Shilpa Mankikar, an h-index of 6, ranking #3,186,836 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shilpa Mankikar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.